Thrombolysis in acute pulmonary embolism.

Tiago Spiazzi Bottega Marcele Gnata Vier Hugo Baldiaserotto Ellen Pierre de Oliveira Claudia Liliana Moreno Diaz Caio Julio Cesar Dos Santos Fernandes

Published in: Revista da Associacao Medica Brasileira (1992) (2020)

Thrombolysis in patients with high-risk APE or intermediate-high risk had a severe bleeding rate of 17.6%. However, the high mortality of this population (47%) due to right ventricular failure justifies the use of this therapeutic modality.

Keyphrases

pulmonary embolism
inferior vena cava
liver failure
drug induced
atrial fibrillation
cardiovascular events
respiratory failure
early onset
risk factors
cardiovascular disease
aortic dissection
coronary artery disease
hepatitis b virus
extracorporeal membrane oxygenation